CURE-Med B

AI benchmark · Healthcare

Tier
B why
Snapshot

Full listing name: CURE-Med: Curriculum-Informed Reinforcement Learning for Multilingual Medical Reasoning

What is CURE-Med?

While large language models (LLMs) have shown to perform well on monolingual mathematical and commonsense reasoning, they remain unreliable for multilingual medical reasoning applications, hindering their deployment in multilingual healthcare settings. We address this by first introducing CUREMED-BENCH, a high-quality multilingual medical reasoning dataset with open-ended reasoning queries with a single verifiable answer, spanning thirteen languages, including underrepresented languages such as Amharic, Yoruba, and Swahili. Building on this dataset, we propose CURE-MED, a curriculum-informed reinforcement learning framework that integrates code-switching-aware supervised fine-tuning and Group Relative Policy Optimization to jointly improve logical correctness and language stability. Across thirteen languages, our approach consistently outperforms strong baselines and scales effectively, achieving 85.21% language consistency and 54.35% logical correctness at 7B parameters, and 94.96% language consistency and 70.04% logical correctness at 32B parameters. These results support reliable and equitable multilingual medical reasoning in LLMs. The code and dataset are available at https://cure-med.github.io/

Tier B

B

Established: 15 or more models scored, or curated RL directories rate it.

How much stands behind a tier: usage, who backs it, a confirmed line from its own site or paper, and a clear read on X. High with three of the four, medium with two, low otherwise.

  • 20 models scored
  • in curated RL directories (1 pt)
How we got to tier B
  1. Adoption: 20 models scored. Tier B.
  2. Not yet read on X.
  3. In curated RL directories: 1 point, a floor of none.
  4. Not yet confirmed by a line from its own site or paper.

A clear view on X moves a tier one step up or down; most entries don't move. How tiers work.

Not on the map yet: no line from its own site or paper places it in a domain.

Next: browse all benchmarks. Entry from the RL Research daily scrape of public sources, 2026-10-11 snapshot.